The need for effective cancer treatments is a top priority in drug development, but oncology trials are inherently complex and unpredictable. Choosing the right IRT can make trial management more efficient, reduce human errors, and keep your trial on time and on budget.
In this webinar, Why the Right IRT Partner Is Key to Oncology Trial Success, industry experts share firsthand perspectives on the value of IRT in support of oncology studies.
Presenters
Isaac Blum
Senior Manager of Clinical Supply at ALX Oncology
Senior Manager of Clinical Supply at ALX Oncology
Swetha Reddy
Director of Services Delivery at Suvoda
This presentation is sponsored by BioPharma Dive and Suvoda.